SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 10/15/2024 at 22:10, 1 month 5 days ago

Sanofi publie ses données sur les actions et les droits de vote pour septembre 2024

Droit De Vote Sanofi Informations Pour Les Investisseurs Septembre 2024 Partage Des Données
BRIEF

published on 10/15/2024 at 22:10, 1 month 5 days ago

Sanofi Reports Share and Voting Rights Data for September 2024

Voting Rights Investor Information Sanofi September 2024 Shares Data
PRESS RELEASE

published on 10/15/2024 at 22:05, 1 month 5 days ago

Sanofi: Informations relatives au nombre de droits de vote et d'actions - SEPTEMBRE 2024
Sanofi communique sur le nombre total de droits de vote et d'actions conformément aux réglementations en vigueur

Autorité Des Marchés Financiers Droits De Vote Actions Règlement Général Sanofi
PRESS RELEASE

published on 10/15/2024 at 22:05, 1 month 5 days ago

Sanofi: Information concerning the total number of voting rights and shares - September 2024
Sanofi reports total number of voting rights and shares as of September 30, 2024, in compliance with French commercial and stock market regulations

Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
BRIEF

published on 10/11/2024 at 08:35, 1 month 10 days ago

Sanofi envisage de céder une part majoritaire d'Opella

Participations Santé Sanofi CD&R Opella
BRIEF

published on 10/11/2024 at 08:35, 1 month 10 days ago

Sanofi considers selling majority stake in Opella

Participations Health Sanofi CD&R Opella
PRESS RELEASE

published on 10/11/2024 at 08:30, 1 month 10 days ago

Press Release: Sanofi in discussions to sell a controlling stake in Opella
Sanofi is in discussions to sell a controlling stake in Opella, its consumer healthcare business, to CD&R. Opella aims for independence aligning with Sanofi’s focus on innovative medicines and vaccines

Negotiations Sale Sanofi Consumer Healthcare Opella
PRESS RELEASE

published on 10/11/2024 at 08:30, 1 month 10 days ago

Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella
Sanofi entame des discussions pour céder une participation majoritaire dans Opella à CD&R. Projet d'indépendance pour Opella aligné avec la stratégie de Sanofi. Opella est un acteur mondial en santé grand public

Cession Santé Sanofi CD&R Opella
BRIEF

published on 10/09/2024 at 07:05, 1 month 12 days ago

Sanofi souligne l'efficacité de Beyfortus contre le VRS chez les nourrissons

Sanofi VRS Beyfortus Nourrissons Semaine Des ID 2024
BRIEF

published on 10/09/2024 at 07:05, 1 month 12 days ago

Sanofi Highlights Beyfortus Effectiveness Against RSV in Infants

Sanofi RSV Beyfortus Infants IDWeek 2024

Accesswire

Published on 11/21/2024 at 12:00, 1 hour 4 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 1 hour 4 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 34 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 3 hours 1 minute ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 3 hours 4 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 28 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 49 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 57 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 3 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 34 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 6 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 6 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 6 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 56 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 44 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE